tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Bicara Therapeutics upgraded to Equal Weight from Underweight at Wells Fargo

Wells Fargo analyst Eva Fortea Verdejo upgraded Bicara Therapeutics (BCAX) to Equal Weight from Underweight with an unchanged price target of $8.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1